|4Sep 16, 5:28 PM ET

KALAJIAN TONY T 4

4 · OncoCyte Corp · Filed Sep 16, 2019

Insider Transaction Report

Form 4
Period: 2019-09-13
Kalajian Tony T
SVP-Chief Accounting Officer
Transactions
  • Purchase

    Common Stock, no par value

    2019-09-13$1.98/sh+10,000$19,80010,000 total
Footnotes (1)
  • [F1]The price of $1.98 per share represents a weighted average of prices ranging from $1.94 to $1.987 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION